With Oxford Nanopore Stake, Illumina Makes Another Claim In Third-Generation Sequencing

Illumina made the investment to help the company develop its so-called Base technology, which couples an exonuclease and a protein nanopore for sequencing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.